RimasLukasMD

PubMed

• Is modulation of immune checkpoints on glioblastoma-infiltrating myeloid cells a viable therapeutic strategy?
  Ruochen Du, Jianzhong Zhang, Rimas V Lukas, Shashwat Tripathi, Jared T Ahrendsen
  Neuro-Oncology. 2024-10-19
• Pediatric glioma immune profiling identifies TIM3 as a therapeutic target in BRAF fusion pilocytic astrocytoma.
  Shashwat Tripathi, Hinda Najem, Corey Dussold, Sebastian Pacheco, Ruochen Du
  The Journal of Clinical Investigation. 2024-08-13
• Long-term outcomes of central neurocytoma - an institutional experience.
  Yufan Yang, Nitin Wadhwani, Aoi Shimomura, Shuhua Zheng, James Chandler
  Journal of Neuro-Oncology. 2024-08-01

Journal Articles

• Delayed Leptomeningeal Metastasis of an Adult Anaplastic Pilocytic Astrocytoma  
  Rimas V Lukas, Douglas E Anderson, Edward Melian, John P Leonetti, Daniel M Heiferman, Ewa Borys, Nawal Shaikh, Brain Tumor Pathology
• Updates from the Neuro-Oncology Section of the 2015 American Neurological Association Annual Meeting  
  Lukas RV, Wainwright DA, Laterra JJ, Future Oncology, 1/1/2016
• Atypical ganglioneurocytoma: case report and review of the literature  
  Eliyas JK, Pytel P, Lukas RV, Gabikian P, Case Reports in Clinical Pathology, 1/1/2015
• Is case specificity a given? The reliability of a neurology clerkship objective structured clinical examination (OSCE) as examined through a generalizability study  
  Blood A, Park YS, Lukas RV, Brorson JR, Neurology, 1/1/2015
• The kyneurenine to tryptophan ratio as a prognostic tool for glioblastoma patients enrolling in immunotherapy  
  Zhai L, Dey M, Lauing KL, Gristina G, Kaur R, Lukas RV, Nicholas MK, Rademaker AW, Dostal CR, McCusker RHM, Raizer JJ, Parsa AT, Bloch O, Wainwright DA, Journal of Clinical Neuroscience, 1/1/2015
• ROS1 rearranged non-small-cell lung cancer brain metastases responding to low dose radiotherapy  
  Lukas RV, Hasan Y, Nicholas MK, Salgia R, Journal of Clinical Neuroscience, 1/1/2015
• Structure of neuroscience clerkships in medical schools and matching in the neuromedicine  
  Albert DV, Yin H, Amidei C, Dixit KS, Brorson JR, Lukas RV, Neurology, 1/1/2015
• Society for Neuro-Oncology 2014 annual meeting updates on central nervous system metastases  
  Lukas RV, Mehta MP, Lesniak MS, Neuro-Oncology Practice, 1/1/2015
• Treatment of leptomeningeal carcinomatosis: current challenges and future opportunities  
  Kak M, Nanda R, Ramsdale EE, Lukas RV, Journal of Clinical Neuroscience, 1/1/2015
• Paraneoplastic nerve hyperexcitability  
  Liebenthal JA, Rezania K, Nicholas MK, Lukas RV, Neurology Research, 1/1/2015
• Assessment of neurological clinical management reasoning in medical students  
  Lukas RV, Blood A, Park YS, Brorson JR, Journal of Clinical Neuroscience, 1/1/2014
• Education research: case logs in the assessment of medical students in the outpatient neurology clinic  
  Albert DV, Brorson JR, Amidei C, Lukas RV, Neurology, 1/1/2014
• Leptomeningeal carcinomatosis from breast cancer treated with intrathecal topotecan with concomitant eribulin  
  Salgia S, Fleming GF, Lukas RV, Journal of Clinical Neuroscience, 1/1/2014
• Advanced neuro-imaging studies in a patient with brain metastases from transitional cell carcinoma of the bladder  
  Choi YJ, Gabikian P, Zhu F, Appelbaum DE, Wollmann R, Lukas RV, Journal of Neuroimaging, 1/1/2014
• Brain metastases in non-small cell lung cancer-better outcomes through current therapies and utilization of molecularly targeted approaches  
  Lukas RV, Lesniak MS, Salgia R, CNS Oncology, 1/1/2014
• Clinical neuro-oncology formal education opportunities for medical students in the US and Canada  
  Dixit KS, Nicholas MK, Lukas RV, World Neurosurgery, 1/1/2014
• Updates from the 2013 Society for Neuro-Oncology annual and World Federation for Neuro-Oncology quadrennial meeting  
  Lukas RV, Amidei C, Tumori, 1/1/2014
• Case challenge: dissecting the case of a 16-year-old male with dizziness, parasthesias, and ataxia  
  Tsien MZ, Brorson JR, Lukas RV, Dawson EC, Pediatric Annals, 1/1/2014
• Attitudes towards neurosciences in medical students in Wuhan, China: a survey study  
  Lukas RV, Cooper B, Morgan I, Brorson JR, Dong H, Sherer R, World Neurosurgery, 1/1/2014
• Anti-NMDA receptor encephalitis: diagnosis, optimal management and challenges  
  Mann A, Grebenciucova E, Lukas RV, Therapeutics and Clinical Risk Management, 1/1/2014
• Leptomeningeal carcinomatosis in esophageal cancer: a case series and systematic review of the literature  
  Lukas RV, Mata-Machado NA, Nicholas MK, Salgia R, Antic T, Villaflor VM, Diseases of the Esophagus, 1/1/2014
• Bilateral optic disc swelling noted with spectral OCT in a patient with acute decreased vision following anastrazole therapy  
  Coppes OJM, Lukas RV, Fleming GF, Nichols J, Tenney M, Bernard J, Neuro-Ophthalmology, 1/1/2014
• Optic nerve radiation recall associated with prior pemetrexed  
  Lukas RV, Bernard JT, Malik R, Finch A, Salgia R, Journal of Neurology Research, 1/1/2013
• Update on the treatment of high-grade gliomas  
  Lukas RV, Nicholas MK, Neurologic Clinics, 1/1/2013
• Accrediting neurology fellowships accelerates subspecialization  
  Hodgson TS, Brorson JR, Ardelt AA, Lukas RV, Frontiers in Neurology, 1/1/2013
• Join now to see all

Books/Book Chapters

• Cancer Consult: Expertise for Clinical Practice 
  Chapter: Secondary CNS Tumors 
  Lukas RV, Gabikian P, Chmura SWiley-Blackwell Healthsciences2014
• Youmans Textbook of Neurological Surgery 
  Chapter: AIDS 
  Nicholas MK, Lukas R, van Besein K2011
• Emerging Cancer Therapeutics 
  Chapter: Management of central nervous system metastases from renal cancer 
  Page 157 - 168Lukas RV, Chmura S, Nicholas MK2011
• The Brain and Host Defense, Volume 9. Immunologic privilege and the brain 
  Chapter: Neuroimmune Biology 
  Nicholas MK, Lukas RElsevier2010
• Join now to see all

Abstracts/Posters

• Extraneural metastasis of high-grade gliomas: systematic review of literature and a discussion of the roles of circulating tumor cells and immune system in gliomagenesis.
  Daher A, Lukas RV, Nicholas MK, American Academy of Neurology, Vancouver, Canada, 1/21/2016
• Successful treatment of intracranial inflammatory pseudotumor with cyclophosphamide.
  Stroup T, Javed A, Arndt N, Lukas R, Rezania K, Polster S, American Academy of Neurology, Washington, DC, 1/22/2015
• Structure of Neuroscience clerkships in medical schools and matching in the neurosciences.
  Albert DV, Lukas R, Brorson J, Amidei C, Dixit K, Han Y, American Academy of Neurology, Washington, DC, 1/22/2015
• ReACT: Long-term survival from a randomized phase II study of rindopepimut (CDX-110) plus bevacizumab in relapsed glioblastoma
  Reardon D, Schuster J, Tran D, Fink K, Nabors L, Li G, Bota, Lukas RV, Desjardins A, Asby LS, Duic JP, Aneiro L, Mrugala MM, Werner A, Hawthorne T, He Y, Green J, Yell..., IMCT-08, Society for Neuro-Oncology, San Antonio, TX, 1/1/2015
• Extraneural metastasis of high-grade gliomas: Systematic review of literature and a discussion of the immune system role in glioma growth.
  Daher A, Lukas RV, Nicholas MK, Society for Neuro-Oncology, San Antonio, TX, 1/1/2015
• Updates on phase 1b/2 combination study of the IDO pathway inhibitor indoximod with temozolomide for adult patients with temozolomide-refractory primary malignant brai...
  Zhakaria Y, Coleman H, Mott F, Lukas RV, Vahanian N, Link, Kennedy G, Sadek R, Munn D, Rixe O, Society for Neuro-Oncology, San Antonio, TX, 1/1/2015
• Clinical activity and safety of atezolizumab (anti-PDL1) in patients with glioblastoma (GBM).
  Lukas RV, Roddon J, Shih K, Wong ET, Becker K, Fasso M, Chappey C, Bais C, O'Hear C, Baehring J, Late breaking abstract, Society for Neuro-Oncology, San Antonio, TX, 1/1/2015
• ReACT: overall survival from a randomized phase II study of rindopepimut (CDX-110) plus bevacizumab in relapsed glioblastoma.
  Reardon D, Schuster J, Tran D, Fink K, Nabors L, Li G, Bota, Lukas RV, Desjardins A, Asby LS, Duic JP, Aneiro L, Mrugala MM, Werner A, Hawthorne T, He Y, Green J, Yell..., Congress of Neurological Surgeons, Neurosurgery, New Orleans, LA, 1/1/2015
• ReACT: overall survival from a phase II study of rindopepimut (CDX-110) plus bevacizumab in relapsed glioblastoma.
  Reardon D, Schuster J, Tran D, Fink K, Nabors L, Li G, Lukas RV, Desjardins A, Asby L, Duic JP, Aneiro L, Hawthorne T, Green J, Yellin M, Davis T, Sampson J, The ReACT..., American Society for Clinical Oncology, J Clin Oncol, Chicago, IL, 1/1/2015
• Breadth vs. Volume: the outpatient neurology clinic experience in medical education.
  Albert DV, Blood A, Park YS, Brorson JR, Lukas RV, 1/1/2015
• ReACT: a phase II study of rindopepimut vaccine (CDX-110) plus bevacizumab in relapsed glioblastoma.
  Reardon D, Schuster J, Tran D, Fink K, Nabors L, Li G, Lukas R, Desjardins A, Asby L, Duic JP, Aneiro L, Hawthorne T, Green J, Yellin M, Davis T, Sampson J, Society for Neuro-Oncology, Miami Beach, FL, 1/14/2014
• Subspecialization in neurology: historical perspectives on present challenges.
  Hodgson TS, Lukas RV, American Academy of Neurology, Philadelphia, PA, 1/1/2014
• Bilateral optic disc swelling noted with spectral OCT in a patient with acute decreased vision following anastrazole therapy.
  Coppes OJM, Lukas RV, Fleming GF, Nichols J, Tenney M, Bernard J, Society for Hospital Medicine, Las Vegas, NV, 1/1/2014
• Bilateral papilledema noted with spectral OCT in a patient with acute visual changes following anastrazole therapy.
  Coppes M, Lukas RV, Nichols J, Fleming G, Tenney M, Bernard J, American Academy of Neurology, San Diego, CA, 1/21/2013
• Case logs in the assessment of medical students in the outpatient clinic component of a neurology clerkship.
  Albert DV, Brorson JR, Amidei C, Lukas RV, American Academy of Neurology, San Diego, CA, 1/20/2013
• Final results of a single-arm phase II study of bevacizumab and temozolomide following radiochemotherapy in newly diagnosed adult glioblastoma patients.
  Nicholas MK, Lukas RV, Amidei C, Vick N, Paleologos N, Malkin MG, Krouwer H, Junck L, Arzbaecher J, Lai A, Merrell R, American Society for Clinical Oncology, J Clin Oncol, Chicago, IL, 1/1/2013
• The reliability of a neurology clerkship Objective Structured Clinical Examination (OSCE) as examined through a generalizability study.
  Blood A, Park YS, Lukas RV, Brorson JR, National Council of Measurement in Education, San Francisco, CA, 1/1/2013
• Advanced imaging studies in a patient with transitional cell carcinoma of the bladder with brain metastases.
  Choi YJ, Gabikian P, Zhu F, Appelbaum DE, Wollman R, Lukas RV, Society for Neuro-Oncology, Washington, DC, 1/16/2012
• Imaging Glioblastoma: Neuroradiology from the Neuro-Oncologists perspective.
  Chua R, Buckle C, Lukas RV, Poon C, American Society of Neuro-Radiology, 1/1/2012
• Intracranial inflammatory psuedotumor: report of two cases.
  Shah A, Javed A, Lukas RV, Rezania K, American Academy of Neurology, New Orleans, LA, 1/1/2012
• Avastin and temozolomide following radiation and chemotherapy for newly diagnosed glioblastoma: interim results of a phase II study.
  Nicholas MK, Chmura S, Vick N, Paleologos N, Krouwer H, Malkin M, Junck L, Merrell R, Corbin K, Arzbaecher J, Lukas R, Neuro-Oncology, Society for Neuro-Oncology, Orange County, CA, 1/18/2011
• The role of Objective Standardized Clinical Evaluation (OSCE) in evaluation of student performance in a neurology clerkship.
  Adesoye T, Lukas RV, Smith SG, Brorson J, American Academy of Neurology, 1/12/2011
• E.T. (T): A different dimension of tumor.
  Drazer MW, Lee NK, Lukas RV, Liauw SL, American College of Physicians-Internal Medicine Regional Meeting, Chicago, IL, 1/4/2011
• Thiamine deficiency presenting with encephalopathy and optic neuropathy after chemoradiation for tongue cancer.
  Lukas RV, Piantino J, Nichols, Cohen E, Haraf DJ, Rezania K, American Academy of Neurology, Toronto, Canada, 1/15/2010
• Ocular melanoma metastasis to the cervical spine: a case report.
  Shakur S, Takagi I, Lukas R, Chmura S, Roitberg BZ, American Association of Neurological Surgeons/Congress of Neurological Surgeons-Joint Section of Disorders of the Spine and Peripheral Nerves, New Orleans, LA, 1/1/2009
• Join now to see all

Lectures

• Evaluation of controlled IL-12 as monotherapy in subjects with recurrent GBM. 
  ASCO Annual Meeting 2019 - Chicago, IL - 6/2/2019
• Spinal Cord 
  Wuhan University Medical School, Wuhan, Hubei province, China - 1/30/2015
• Checkpoint Inhibitors for the Treatment of CNS Tumors 
  Chicago, IL - 1/27/2015
• Remote Effects of Cancer of the Nervous System 
  St. Joseph's Medical Center, Chicago, IL - 1/25/2015
• Recent Advances in Neuro-Oncology: from Immunotherapy to Magnetic Fields 
  Loyola University, Chicago, IL, 2015; University of Chicago, Chicago, IL, 2015 - 1/22/2015
• Brain and Spinal Lesions: Not Just a Science 
  Rolling Meadows, IL - 1/17/2015
• CNS Manifestations of Systemic Cancers 
  University of Illinois-Chicago, Chicago, IL - 1/10/2015
• Advances in Neuro-Oncology: From Electrical Fields to Immunotherapy 
  Zhognan Hospital, Wuhan University, Wuhan, Hubei province, China - 1/3/2015
• Neurologic Complications of Cancer 
  Wuhan University Medical School, Wuhan, Hubei province, China - 1/3/2015
• Advances in Neuro-Oncology 
  Wuhan University Medical School, Wuhan, Hubei province, China - 1/1/2015
• Management of Primary Brain Tumors 
  San Antonio, TX - 1/1/2015
• Driving in the Context of Seizures and Brain Tumors 
  San Antonio, TX - 1/1/2015
• Neuro-Oncology 
  Loyola University, Maywood, IL - 1/11/2014
• Neuro-Oncology for the Internist 
  Mercy Hospital, Chicago, IL - 1/8/2014
• Clinical Cases: Round Table 
  Hospital Italiano de Buenos Aires, Buenos Aires, Argentina - 1/6/2014
• Treatment of Brain Metastases 
  Hospital Italiano de Buenos Aires, Buenos Aires, Argentina - 1/6/2014
• Treatment of High-Grade Gliomas 
  Hospital Italiano de Buenos Aires, Buenos Aires, Argentina - 1/6/2014
• Nervous System Malignancies 
  University of Illinois-Chicago, Chicago, IL - 1/1/2014
• The Pass Machine Internal Medicine MOC Course 
  American Physician Institute for Advanced Professional Studies, Lake Buena Vista, Florida - 2/28/2013
• Intro To and Update On Neuro-Oncology 
  St. Joseph's Medical Center, Chicago, IL - 1/16/2013
• Updates in the Treatment of Glioblastoma 
  University of Chicago, Chicago, I - 1/13/2013
• Introduction to and Update on Neuro-Oncology 
  Vista Health Center, Cancer Care, Gurnee, IL - 1/8/2012
• Epilepsy for the Internist 
  Mercy Hospital, Chicago, IL - 1/8/2012
• Neurologic Localization for the Internist 
  Mercy Hospital, Chicago, IL - 1/4/2012
• Introduction to Neuro-Oncology 
  Wuhan University-Wuhan, Hubei Province, China - 1/23/2011
• Join now to see all

Other

• Dr. Rimas Lukas on the future of checkpoint inhibitors in recurrent glioblastoma 
  Lukas R, Targeted Oncology
  http://www.targetedonc.com/conference/2015-sno-annual-meeting/dr-rimas-lukas-on-the-future-of-checkpoint-inhibitors-in-recurrent-glioblastoma
  1/20/2015
• New approaches to treat brain cancers raise hopes 
  Lukas R, Clinical Oncology interview
  http://www.clinicaloncology.com/ViewArticle.aspx?d=Solid+Tumors&d_id=148&i=October+2015&i_id=1236&a_id=34003
  1/19/2015
• Primary diffuse large B-cell lymphoma of the central nervous system: Part 1: Approach to diagnosis in the immunocompetent patient 
  Abutalib S, Lukas RV, ASCO Post
  http://www.ascopost.com/issues/october-25,-2015/q-primary-diffuse-large-b-cell-lymphoma-of-the-central-nervous-system.aspx
  1/1/2015
• Primary diffuse large B-cell lymphoma of the central nervous system: Part 2: Assessment of disease burden and prognosis in the immunocompetent host. 
  Abutalib S, Lukas RV, ASCO Post
  http://www.ascopost.com/issues/november-10,-2015/q-primary-diffuse-large-b-cell-lymphoma-of-the-central-nervous-system.aspx
  1/1/2015
• Primary diffuse large B-cell lymphoma of the central nervous system: Part 3: Therapeutic considerations and response assessment. 
  Abutalib S, Lukas RV, ASCO Post
  http://www.ascopost.com/issues/december-25,-2015/q-primary-diffuse-large-b-cell-lymphoma-of-the-central-nervous-system.aspx
  1/1/2015
• Wasp, scorpion venom could help in fighting cancer, researchers say 
  Lukas R, CBS local news
  http://chicago.cbslocal.com/2015/09/01/wasp-scorpion-venom-could-be-help-in-fighting-cancer-researchers-say/
  1/1/2015
• The Neurology Clerkship Objective Structured Clinical Examination (OSCE) 
  Blood A, Brorson JR, Lukas RV, MedEdPORTAL
  www.mededportal.org/publication/9368
  1/1/2013
• Program director highlight 
  Lukas R, UCNS Newsletter
  https://www.ucns.org/globals/axon/assets/11223.PDF
  1/1/2011
• Pharmacy student, now grad, helps save father's life 
  Lukas R, American Physicians Institute
  1/1/2009
• Synthetic venom shows promise as brain tumor treatment 
  Lukas R, Chicago Tribune
  http://articles.chicagotribune.com/2008-09-28/features/0809241278_1_giant-yellow-israeli-scorpion-tm601-glioma
  1/28/2008
• Clinical vignettes and questions. 
  Lukas R, American Physicians Institute Neurology Board Review course
  1/1/2008
• Synthetic venom shows real promise on tumors 
  Lukas R, American Physicians Institute
  1/1/2008
• Neurology Board Review course, question set 
  Lukas R, Tech Transfer E-News Blog
  http://techtransfercentral.com/2008/10/01/synthetic-venom-shows-promise-as-brain-tumor-treatment/
  1/1/2008
• Join now to see all